205 related articles for article (PubMed ID: 27270564)
1. Gene-environment interaction between the MMP9 C-1562T promoter variant and cigarette smoke in the pathogenesis of chronic obstructive pulmonary disease.
Stankovic M; Kojic S; Djordjevic V; Tomovic A; Nagorni-Obradovic L; Petrovic-Stanojevic N; Mitic-Milikic M; Radojkovic D
Environ Mol Mutagen; 2016 Jul; 57(6):447-54. PubMed ID: 27270564
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.
Ito I; Nagai S; Handa T; Muro S; Hirai T; Tsukino M; Mishima M
Am J Respir Crit Care Med; 2005 Dec; 172(11):1378-82. PubMed ID: 16126934
[TBL] [Abstract][Full Text] [Related]
3. [Polymorphism in promoter regions of matrix metalloproteinases (MMP1, MMP9, and MMP12) in chronic obstructive pulmonary disease patients].
Korytina GF; Akhmadishina LZ; Ianbaeva DG; Viktorova TV
Genetika; 2008 Feb; 44(2):242-9. PubMed ID: 18619044
[TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.
Bchir S; Nasr HB; Hakim IR; Anes AB; Yacoub S; Garrouch A; Benzarti M; Bauvois B; Tabka Z; Chahed K
Mol Diagn Ther; 2015 Dec; 19(6):375-87. PubMed ID: 26303146
[TBL] [Abstract][Full Text] [Related]
5. Gene-Gene Interactions Between Glutathione S-Transferase M1 and Matrix Metalloproteinases 1, 9, and 12 in Chronic Obstructive Pulmonary Disease in Serbians.
Stankovic M; Nikolic A; Nagorni-Obradovic L; Petrovic-Stanojevic N; Radojkovic D
COPD; 2017 Dec; 14(6):581-589. PubMed ID: 28949773
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Xu L; Cai BQ; Zhu YJ
Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China.
Zhou M; Huang SG; Wan HY; Li B; Deng WW; Li M
Chin Med J (Engl); 2004 Oct; 117(10):1481-4. PubMed ID: 15498369
[TBL] [Abstract][Full Text] [Related]
8. [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease].
Korytina GF; Tselousova OS; Akhmadishina LZ; Victorova EV; Zagidullin ShZ; Victorova TV
Mol Biol (Mosk); 2012; 46(3):487-99. PubMed ID: 22888638
[TBL] [Abstract][Full Text] [Related]
9. Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm.
Jones GT; Phillips VL; Harris EL; Rossaak JI; van Rij AM
J Vasc Surg; 2003 Dec; 38(6):1363-7. PubMed ID: 14681642
[TBL] [Abstract][Full Text] [Related]
10. Identification of genetic variants in the TNF promoter associated with COPD secondary to tobacco smoking and its severity.
Reséndiz-Hernández JM; Sansores RH; Hernández-Zenteno Rde J; Vargas-Alarcón G; Colín-Barenque L; Velázquez-Uncal M; Camarena A; Ramírez-Venegas A; Falfán-Valencia R
Int J Chron Obstruct Pulmon Dis; 2015; 10():1241-51. PubMed ID: 26170653
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of matrix metalloproteinases: functional importance in the development of chronic obstructive pulmonary disease?
Wallace AM; Sandford AJ
Am J Pharmacogenomics; 2002; 2(3):167-75. PubMed ID: 12383023
[TBL] [Abstract][Full Text] [Related]
12. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases gene variants in idiopathic disseminated bronchiectasis.
Stankovic M; Nikolic A; Divac A; Rakicevic L; Tomovic A; Mitic-Milikic M; Nagorni-Obradovic L; Grujic M; Petrovic-Stanojevic N; Andjelic-Jelic M; Dopudja-Pantic V; Radojkovic D
J Investig Med; 2009 Mar; 57(3):500-3. PubMed ID: 19188843
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.
Minematsu N; Nakamura H; Tateno H; Nakajima T; Yamaguchi K
Biochem Biophys Res Commun; 2001 Nov; 289(1):116-9. PubMed ID: 11708786
[TBL] [Abstract][Full Text] [Related]
15. A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9.
Nakamaru Y; Vuppusetty C; Wada H; Milne JC; Ito M; Rossios C; Elliot M; Hogg J; Kharitonov S; Goto H; Bemis JE; Elliott P; Barnes PJ; Ito K
FASEB J; 2009 Sep; 23(9):2810-9. PubMed ID: 19376817
[TBL] [Abstract][Full Text] [Related]
16. Infection of
Le Y; Cao W; Zhou L; Fan X; Liu Q; Liu F; Gai X; Chang C; Xiong J; Rao Y; Li A; Xu W; Liu B; Wang T; Wang B; Sun Y
Front Immunol; 2020; 11():1902. PubMed ID: 32973788
[TBL] [Abstract][Full Text] [Related]
17. Il13 promoter (-1055) polymorphisms associated with chronic obstructive pulmonary disease in Taiwanese.
Liu SF; Chen YC; Wang CC; Fang WF; Chin CH; Su MC; Lin MC
Exp Lung Res; 2009 Dec; 35(10):807-16. PubMed ID: 19995275
[TBL] [Abstract][Full Text] [Related]
18. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smoking-related COPD in Thailand.
Chierakul N; Wongwisutikul P; Vejbaesya S; Chotvilaiwan K
Respirology; 2005 Jan; 10(1):36-9. PubMed ID: 15691236
[TBL] [Abstract][Full Text] [Related]
20. [The study of interleukin-13 gene promoter polymorphism in patients with chronic obstructive pulmonary disease].
He B; Zhao MW; Ning LD; Jiang L; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):529-32. PubMed ID: 15388001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
